Arbutus Biopharma (ABUS) Preferred Dividend Payments (2017 - 2021)

Arbutus Biopharma has disclosed Preferred Dividend Payments across 5 years of filings, most recently posting $574000.0 for Q4 2021.

• Preferred Dividend Payments for Q4 2021 came in at $574000.0, down 81.62% year-over-year; the trailing twelve-month figure through Sep 2022 was $574000.0 (down 96.09% YoY), and the FY2021 annual result was $12.1 million, changed 0.13% from the prior year.
• Preferred Dividend Payments came in at $574000.0 for Q4 2021 at Arbutus Biopharma, down from $5.1 million in the prior quarter.
• In the past five years, Preferred Dividend Payments ranged from a high of $5.1 million in Q3 2021 to a low of $574000.0 in Q4 2021.
• The 5-year median for Preferred Dividend Payments is $2.8 million (2019), against an average of $2.7 million.
• Across the five-year window, Preferred Dividend Payments jumped 190.56% in 2018 and tumbled 81.62% in 2021, its largest moves.
• Arbutus Biopharma's Preferred Dividend Payments stood at $911000.0 in 2017, then soared by 190.56% to $2.6 million in 2018, then climbed by 8.8% to $2.9 million in 2019, then increased by 8.44% to $3.1 million in 2020, then plunged by 81.62% to $574000.0 in 2021.
• The last three Preferred Dividend Payments figures came in at $574000.0 (Q4 2021), $5.1 million (Q3 2021), and $3.3 million (Q2 2021), per Business Quant data.